Should Postprandial Hyperglycaemia in Prediabetic and Type 2 Diabetic Patients be Treated?

Author： Charpentier Guillaume   Riveline Jean-Pierre   Dardari Dured   Varroud-Vial Michel  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.3, 2006-01, pp. : 273-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How should epilepsy in elderly patients be treated?

By  

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Statins for cholesterol reduction – who should be treated?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 319, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Statins for cholesterol reduction – who should be treated?

By  

Inpharma, Vol. 1, Iss. 1294, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Defining the Role of Insulin Lispro in the Management of Postprandial Hyperglycaemia in Patients with Type 2 Diabetes Mellitus

By Giugliano D.  

Clinical Drug Investigation, Vol. 28, Iss. 4, 2008-01 ,pp. : 199-210

Adis International

Access to resources Recommend Favorite

Should the Insulin Resistance Syndrome be Treated in the Elderly?

By Grant R.W.   Meigs J.B.  

Drugs & Aging, Vol. 21, Iss. 3, 2004-01 ,pp. : 141-151

Adis International

Access to resources Recommend Favorite